☆ 4.8 Editorial Material

Welcoming Treat: Astrocyte-Derived Exosomes Induce PTEN Suppression to Foster Brain Metastasis

CANCER CELL (2015)

Journal

CANCER CELL

Volume 28, Issue 5, Pages 554-556

Publisher

CELL PRESS

DOI: 10.1016/j.ccell.2015.10.010

Keywords

-

Categories

Oncology Cell Biology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Leukemia-derived Exosomes Can Induce Responses Related to Tumorigenesis on Non-tumoral Astrocytes

Parisa Zamani Esmati, Javad Baharara, Sajad Sahab-Negah, Khadijeh Nejad Shahrokhabadi

Summary: Cancer is a major global cause of disability and death. Exosomes derived from cancer cells have been identified as a key player in metastatic processes. In our study, we evaluated the effects of exosomes derived from the leukemia nalm6 cell line on astrocyte behavior, finding that they significantly increased astrocyte proliferation and the expression of inflammatory markers. These findings highlight the role of cancer cell secretion in inducing tumorigenesis-related responses and the need for further research on exosomes and metastasis.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2023)

Add to Collection

Article Chemistry, Analytical

Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model

Peng Wang, Yunsong Wu, Wenwen Chen, Min Zhang, Jianhua Qin

Summary: Malignant melanoma-derived exosomes disrupt BBB integrity and induce glial activation. Dys-regulation of autophagy and immune responses is observed following tumor exosome treatment. These findings provide a new platform for studying brain metastasis of tumors in vitro.

BIOSENSORS-BASEL (2022)

Add to Collection

Article Gastroenterology & Hepatology

Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression

Chubin Luo, Haoyang Xin, Zhengjun Zhou, Zhiqiang Hu, Rongqi Sun, Na Yao, Qiman Sun, Uyunbilig Borjigin, Xia Wu, Jia Fan, Xiaowu Huang, Shaolai Zhou, Jian Zhou

Summary: Macrophages in ICC tumor tissues upregulate PD-L1 expression, suppressing T-cell immunity and correlating with poor survival rates. Exosomal miR-183-5p from ICC cells inhibits PTEN expression in macrophages, leading to elevated AKT phosphorylation and PD-L1 expression, contributing to ICC progression. Plasma exosomal miR-183-5p levels are associated with poor prognosis in ICC patients.

HEPATOLOGY (2022)

Add to Collection

Article Cell & Tissue Engineering

Hypoxic Tumor-Derived Exosomes Induce M2 Macrophage Polarization via PKM2/AMPK to Promote Lung Cancer Progression

Shiyu Zhou, Yu Lan, Yuqun Li, Zhenxing Li, Jinding Pu, Liping Wei

Summary: Under hypoxia conditions, exosomes secreted by lung cancer cells can induce macrophage polarization through the AMPK signaling pathway, and promote the proliferation, migration, epithelial-mesenchymal transition, and lung metastasis of lung cancer.

CELL TRANSPLANTATION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression

Qiongyu Hao, Yong Wu, Yanyuan Wu, Piwen Wang, Jaydutt V. Vadgama

Summary: Exosomes are small membrane-bound extracellular vesicles that mediate targeted information transfer by carrying molecular cargo. Tumor-derived exosomes (TEX) differ from normal cell-derived exosomes and have the ability to disrupt receptor discharge and intercellular cross-talk. TEX progressively weakens the immune system defenses by activating suppressive pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Genetics & Heredity

Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization

Wenhao Pei, Ke Wei, Yulun Wu, Quanwei Qiu, Haitao Zhu, Lingyu Mao, Xiuru Shi, Shiwen Zhang, Yingxiang Shi, Shuang Tao, Huilan Mao, Siyan Pang, Jing Wang, Mulin Liu, Wenrui Wang, Qingling Yang, Changjie Chen

Summary: This study reveals that the molecular processes underlying the interaction between TAMs and tumor-derived exosomal miRNAs in liver metastasis of colorectal cancer are not fully understood. It was confirmed that exosomal miR-203a-3p induced M2 polarization of macrophages by controlling PTEN and activating the PI3K/Akt signaling pathway, thus promoting liver metastasis in colorectal cancer.

GENE (2023)

Add to Collection

Article Rheumatology

Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis

Rajan Bhandari, Heetaek Yang, Noelle N. Kosarek, Avi E. Smith, Jonathan A. Garlick, Monique Hinchcliff, Michael L. Whitfield, Patricia A. Pioli

Summary: This study demonstrates that dermal fibroblasts from SSc patients activate macrophages through exosomes. The findings suggest that there is cross-talk between macrophages and fibroblasts in SSc skin, resulting in mutual activation, inflammation, and extracellular matrix deposition.

RHEUMATOLOGY (2023)

Add to Collection

Article Oncology

Extracellular Vesicle-Packaged CDH11 and ITGA5 Induce the Premetastatic Niche for Bone Colonization of Breast Cancer Cells

Xiao-Qing Li, Rui Zhang, Hong Lu, Xiao-Min Yue, Yu-Fan Huang

Summary: This study provides mechanistic insights into the generation of an osteogenic premetastatic niche by breast cancer-derived EVs and identifies potential EV-derived diagnostic biomarkers and targets for breast cancer bone metastasis.

CANCER RESEARCH (2022)

Add to Collection

Article Pharmacology & Pharmacy

Endothelial-Derived Extracellular Vesicles Induce Cerebrovascular Dysfunction in Inflammation

David Roig-Carles, Eduard Willms, Ruud D. Fontijn, Sarai Martinez-Pacheco, Imre Mager, Helga E. de Vries, Mark Hirst, Basil Sharrack, David K. Male, Cheryl A. Hawkes, Ignacio A. Romero

Summary: It has been discovered that small EVs released by inflamed brain endothelial cells may contribute to blood-brain barrier dysfunction, leading to cerebrovascular disorders. The expression of VCAM1 is associated with T-cell adhesion, while ICAM1 does not affect this process.

PHARMACEUTICS (2021)

Add to Collection

Article Materials Science, Biomaterials

Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of Aβ aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer's disease

Qinghao Huo, Yijie Shi, Yao Qi, Lijuan Huang, Haijuan Sui, Liang Zhao

Summary: Alzheimer's disease (AD) is a common neurodegenerative disease, and current clinical drugs are ineffective in preventing its progression. Silibinin (Slb) has potential therapeutic effects on AD, but its application is limited by poor brain targeting ability. Encapsulating Slb in macrophage-derived exosomes improved its brain targeting ability and effectively ameliorated cognitive deficits in AD mice.

MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Add to Collection

Article Cell Biology

Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression

Ziming Jiang, Yiming Zhang, Yu Zhang, Zhankui Jia, Zhengguo Zhang, Jinjian Yang

Summary: The study revealed that exosomes released by bladder cancer cells can promote the immunosuppressive polarization of macrophages, facilitating tumor growth. This process is mediated by down-regulation of PTEN and activation of AKT/STAT3/6 signaling. Inhibiting the generation or secretion of exosomes can suppress the immunosuppressive transformation of macrophages, thereby inhibiting tumor growth.

CELL COMMUNICATION AND SIGNALING (2021)

Add to Collection

Article Immunology

Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma

Seyedeh Alia Moosavian, Maryam Hashemi, Leila Etemad, Sara Daneshmand, Zahra Salmasi

Summary: Exosomes play a crucial role in early diagnosis and various functions related to angiogenesis, immune modulation, migration, metastasis, chemotherapy resistance, and tumor progression in melanoma. Natural exosomes have the potential to be utilized as nanocarriers and cancer vaccines for more efficient cancer treatment in the era of novel bioengineering and immunotherapy approaches.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1

Mengmeng Liang, Xiaofan Yin, Shuai Zhang, Hongbo Ai, Fei Luo, Jianzhong Xu, Ce Dou, Shiwu Dong, Qinyu Ma

Summary: The study reveals that miR-324-contained sEVs released from mature osteoclasts play an essential role in the regulation of osteogenic differentiation and potentially bridge the coupling between osteoclasts and MSCs. The miR-324-enriched sEV-modified scaffold showed the highest capacity on bone regeneration, highlighting the importance of miR-324 in promoting osteogenesis.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Exosomes derived from bone marrow mesenchymal stem cells pretreated with decellularized extracellular matrix enhance the alleviation of osteoarthritis through miR-3473b/phosphatase and tensin homolog axis

Yueqi Zhang, Guobin Qi, Yuheng Yan, Chenzhong Wang, Zhe Wang, Chang Jiang, Zengxin Jiang, Tianle Ma, Chi Zhang, Zuoqin Yan

Summary: This study investigates whether exosomes isolated from bone marrow mesenchymal stem cells (BMSCs) with decellularized extracellular matrix (dECM) pretreatment (dECM-BMSC-Exos) enhance the amelioration of osteoarthritis (OA). The results show that dECM-BMSC-Exos enhance the proliferation, anabolism, migration, and anti-apoptosis properties of chondrocytes compared to BMSC-Exos. In addition, injecting dECM-BMSC-Exos into DMM mice improves cartilage regeneration. The underlying mechanism involves elevated levels of miR-3473b in dECM-BMSC-Exos, which targets PTEN to activate the PTEN/AKT signaling pathway and mediate the protective effect on chondrocytes.

JOURNAL OF GENE MEDICINE (2023)

Add to Collection

Article Oncology

Arginase-1 in Plasma-Derived Exosomes as Marker of Metastasis in Patients with Head and Neck Squamous Cell Carcinoma

Linda Hofmann, Malgorzata Harasymczuk, Diana Huber, Miroslaw J. Szczepanski, Grzegorz Dworacki, Theresa L. Whiteside, Marie-Nicole Theodoraki

Summary: Arginase-1 plays an important role in the clinicopathology and prognosis of head and neck cancer. High tumor Arginase-1 levels are associated with favorable clinicopathology and prognosis, while high plasma Arginase-1 levels are associated with unfavorable clinicopathology. The presence of Arginase-1 in exosomes explains this discrepancy. High levels of exosomal Arginase-1 are associated with lymph node metastasis and shorter recurrence-free survival.

CANCERS (2023)

Add to Collection

Article Endocrinology & Metabolism

Cellular plasticity in bone metastasis

Cao Fang, Yibin Kang

Summary: Metastasis is the leading cause of death in malignant solid tumors, with bone being frequently affected in cancer metastasis. The development of bone metastasis involves cellular and molecular changes that enable cancer cells to adapt to different environments. Understanding these mechanisms is crucial for the development of effective therapies.

BONE (2022)

Add to Collection

Article Oncology

JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Laura E. Stevens, Guillermo Peluffo, Xintao Qiu, Daniel Temko, Anne Fassl, Zheqi Li, Anne Trinh, Marco Seehawer, Bojana Jovanovic, Masa Aleckovic, Callahan M. Wilde, Renee C. Geck, Shaokun Shu, Natalie L. Kingston, Nicholas W. Harper, Vanessa Almendro, Alanna L. Pyke, Shawn B. Egri, Malvina Papanastasiou, Kendell Clement, Ningxuan Zhou, Sarah Walker, Jacqueline Salas, So Yeon Park, David A. Frank, Alexander Meissner, Jacob D. Jaffe, Piotr Sicinski, Alex Toker, Franziska Michor, Henry W. Long, Beth A. Overmoyer, Kornelia Polyak

Summary: Inflammatory breast cancer (IBC) is a difficult-to-treat disease with poor clinical outcomes due to high risk of metastasis and resistance to treatment. CD44(+)CD24(-) cells, which possess stem cell-like features, are the most frequent cell type in IBC and are commonly activated by the JAK2/STAT3 signaling pathway. Combination therapy with JAK2/STAT3 inhibition and paclitaxel has shown promising results in decreasing IBC xenograft growth. Furthermore, single-cell analyses have revealed the mechanisms of chemotherapy resistance and the potential of targeting the cAMP/PKA signaling pathway in IBC.

CANCER RESEARCH (2023)

Add to Collection

Article Chemistry, Multidisciplinary

Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents

Jesse M. McFarland, Masa Aleckovic, George Coricor, Sangeetha Srinivasan, Matthew Tso, John Lee, Tri-Hung Nguyen, Josei M. Mejiia Oneto

Summary: Preclinical experiments demonstrate that the novel protodrug SQP22 can be activated by click chemistry and specifically target tumors using a biopolymer or an antibody fragment. The Click Activated Protodrugs Against Cancer (CAPAC) platform utilizes a click chemistry reaction to activate potent cancer drugs at tumor sites. This study highlights the efficacy of SQP22 in tumor treatment using two different targeting approaches and emphasizes the precise control of drug activation at tumors through click chemistry.

ACS CENTRAL SCIENCE (2023)

Add to Collection

Meeting Abstract Oncology

A click chemistry-activated auristatin protodrug (TCO-MMAE) demonstrates potency and safety with antibody and intratumoral tumor-targeting agents

Jesse M. McFarland, Masa Aleckovic, George Coricor, Sangeetha Srinivasan, Leslie Priddy, Matthew Tso, Tri-Hung Nguyen, John Lee, Jose M. Mejia Oneto

CANCER RESEARCH (2023)

Add to Collection

Meeting Abstract Oncology

CAPAC: a modular platform that can improve the safety and efficacy of existing cancer therapies

George Coricor, Jesse M. McFarland, Masa Aleckovic, Sangeetha Srinivasan, John Lee, Leslie Priddy, Matthew Tso, Tri-Hung Nguyen, Jose M. Mejia Oneto

CANCER RESEARCH (2023)

Add to Collection

Meeting Abstract Oncology

SQ3370, a doxorubicin-based click chemistry therapeutic, promotes a shift from an immunosuppressive towards a T-cell permissive tumor microenvironment in patients

Masa Aleckovic, Sangeetha Srinivasan, John Lee, Jesse M. McFarland, Leslie Priddy, Matthew Tso, Tri-Hung Nguyen, George Coricor, Jose M. Mejia Oneto

CANCER RESEARCH (2023)

Add to Collection

Review Oncology

Cancer fitness genes: emerging therapeutic targets for metastasis

Minhong Shen, Yibin Kang

Summary: The traditional approach to cancer therapeutics targets driver oncogenes, but this method has limitations such as toxicity to normal tissue and treatment resistance. However, a new class of genes called 'cancer fitness genes' have been identified, which play crucial roles in metastasis. These genes help tumor cells adapt to changing microenvironments, facilitating tumor progression and metastasis. They have therapeutic potential as targeting them is less likely to harm noncancerous tissues.

TRENDS IN CANCER (2023)

Add to Collection

Meeting Abstract Oncology

TREATMENT WITH SQ3370, A DOXORUBICIN-BASED THERAPEUTIC, CORRESPONDS WITH IMMUNOMODULATION OF THE TUMOR MICROENVIRONMENT

Masa Aleckovic, Sangeetha Srinivasan, Jesse McFarland, Leslie Priddy, Matthew Tso, Jose Mejia Oneto

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Meeting Abstract Oncology

SQ2270, A NOVEL MMAE-BASED THERAPEUTIC, PROMOTES TUMOR GROWTH INHIBITION AND EXTENSIVE IMMUNE CELL INFILTRATION IN THE RENCA CANCER MODEL

Masa Aleckovic, Sangeetha Srinivasan, Jesse McFarland, Leslie Priddy, Matthew Tso, George Coricor, Jose Mejia Oneto

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Meeting Abstract Oncology

Combining SQ3370, a doxorubicin-based therapeutic, with TLR and STING agonists enhances antitumor effects in murine tumor models.

Masa Aleckovic, Sangeetha Srinivasan, Jesse M. McFarland, Leslie Priddy, Matthew Tso, Jose M. Mejia Oneto

CANCER IMMUNOLOGY RESEARCH (2022)

Add to Collection

Meeting Abstract Oncology

Interim phase 1 results for SQ3370 in advanced solid tumors.

Sant P. Chawla, Kathleen Batty, Masa Aleckovic, Vivek Bhadri, Nam Bui, Alexander David Guminski, Jose Manuel Mejia Oneto, Sangeetha Srinivasan, James Fredric Strauss, Vivek Subbiah, Mia C. Weiss, Rosalind Wilson, Nathan A. Yee, Michael Zakharian, Vineet Kwatra

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Chemistry, Medicinal

Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Inhibitors MTDH and SND1 Interaction

Hailing Chen, Meimiao Zhan, Jianbo Liu, Zhihong Liu, Minhong Shen, Fenfang Yang, Yibin Kang, Feng Yin, Zigang Li

Summary: This study developed a novel class of stabilized peptide inhibitors to disrupt the interaction between MTDH and SND1, showing promising potential as a breast cancer treatment.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Meeting Abstract Oncology

SQ3370: CAPAC platform enables tumor-localized therapy and minimizes systemic toxicities

M. Jose, Mejia Oneto, Sangeetha Srinivasan, Jesse M. McFarland, Matthew Tso, Masa Aleckovic

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Oncology

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer

Ivan Perez-Nunez, Catalina Rozalen, Jose Angel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernandez-Prat, David Casadevall, Silvia Menendez, Daniel Dan Liu, Minhong Shen, Jordi Berenguer, Irene Rius Ruiz, Raul Pena, Jose Carlos Montanes, M. Mar Alba, Sarah Bonnin, Julia Ponomarenko, Roger R. Gomis, Juan Miguel Cejalvo, Sonia Servitja, Diego M. Marzese, Lluis Morey, Leonie Voorwerk, Joaquin Arribas, Begona Bermejo, Marleen Kok, Lajos Pusztai, Yibin Kang, Joan Albanell, Toni Celia-Terrassa

Summary: LCOR plays a critical role in breast cancer stem cell differentiation and immunotherapy. Immune-checkpoint blockade therapy selects for LCORlow cancer stem cells, disrupting antigen processing/presentation mechanisms and leading to immune escape and therapy resistance. LCOR can activate APM genes independently of IFN signaling, regulating tumor immunogenicity.

NATURE CANCER (2022)

Add to Collection

Article Oncology

Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis

Minhong Shen, Yong Wei, Hahn Kim, Liling Wan, Yi-Zhou Jiang, Xiang Hang, Michael Raba, Stacy Remiszewski, Michelle Rowicki, Cheng-Guo Wu, Songyang Wu, Lanjing Zhang, Xin Lu, Min Yuan, Heath A. Smith, Aiping Zheng, Joseph Bertino, John F. Jin, Yongna Xing, Zhi-Ming Shao, Yibin Kang

Summary: Targeting the MTDH-SND1 complex shows significant therapeutic potential for metastatic breast cancer. Specific compounds C26-A2 and C26-A6 inhibit tumor growth and metastasis, as well as enhancing chemotherapy sensitivity.

NATURE CANCER (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.